Companies like Genentech are hoping that personalized cancer vaccines take off, MIT's Technology Review reports.

It notes that the leadership there was initially skeptical that such a treatment could work, but in the years since, advances in genome sequencing as well as figuring out why the human immune system would target some cancer antigens but not other proteins, have helped them and others come around.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Reuters reports that UK researchers are using gene-editing tools to develop flu-resistant chickens.

Nature calls for genomics to become part of the World Health Organization's cholera surveillance approach.

Vox explores a proposal to institute a lottery system to award grant funds.

In Genome Biology this week: gut microbiome study of individuals from Tanzania and Botswana, sixth version of the Network of Cancer Genes database, and more.